FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Zelija Velija-Asimi

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Geographic Areas

Bosnia-Herzegovina

Co-author Network

Publications

TOP 3
Zelija Velija-Asimi
The efficacy of octreotide LAR in acromegalic patients as primary or secondary therapy.
Amina Godinjak; Zulfo Godinjak; Ismana Surkovic; Azra Burekovic; Amela Dizdarevic-Bostandzic; Zelija Velija-Asimi
Insulin resistance and lipid accumulation product in corelation to body mass index in women with polycystic ovary syndrome.
Sabina Semiz; Zelija Velija-Asimi; Tamer Bego; Tanja Dujic; Becir Heljic; Maja Malenica; Janja Marc; Barbara Mlinar; Barbara Ostanek; Besim Prnjavorac; Adlija Causevic
Association of NAT2 polymorphisms with type 2 diabetes in a population from Bosnia and Herzegovina.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Zelija Velija-Asimi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Zelija Velija-Asimi
The efficacy of octreotide LAR in acromegalic patients as primary or secondary therapy.
Therapeutic advances in endocrinology and metabolism 2012;3(1):3-9.
2012: Amina Godinjak; Zulfo Godinjak; Ismana Surkovic; Azra Burekovic; Amela Dizdarevic-Bostandzic; Zelija Velija-Asimi
Insulin resistance and lipid accumulation product in corelation to body mass index in women with polycystic ovary syndrome.
Medicinski arhiv 2012;66(6):409-11.
2011: Sabina Semiz; Zelija Velija-Asimi; Tamer Bego; Tanja Dujic; Becir Heljic; Maja Malenica; Janja Marc; Barbara Mlinar; Barbara Ostanek; Besim Prnjavorac; Adlija Causevic
Association of NAT2 polymorphisms with type 2 diabetes in a population from Bosnia and Herzegovina.
Archives of medical research 2011;42(4):311-7.
2009: Amra Macić-Dzanković; Fuad Dzanković; Belma Pojskić; Zelija Velija-Asimi
Evaluation of risk markers fluctuation during an initial therapy with rosiglitazon in patients suffering from metabolic syndrome.
Bosnian journal of basic medical sciences / Udruženje basičnih mediciniskih znanosti = Association of Basic Medical Sciences 2009;9(4):320-8.
2009: Bećir Heljić; Zelija Velija-Asimi; Mehmed Kulić
The statins in prevention of coronary heart diseases in type 2 diabetics.
Bosnian journal of basic medical sciences / Udruženje basičnih mediciniskih znanosti = Association of Basic Medical Sciences 2009;9(1):71-6.
2007: Radovoj Kocić; Dejan Spirovski; Vojislav Cirić; Zelija Velija-Asimi
Impact of diet, physical activity, lipid status and glycoregulation in estimation of score (systematic coronary risk evaluation) for ten years in postmenopausal women.
Bosnian journal of basic medical sciences / Udruženje basičnih mediciniskih znanosti = Association of Basic Medical Sciences 2007;7(3):197-204.
2007: Zelija Velija-Asimi
C-reactive protein in obese PCOS women and the effect of metformin therapy.
Bosnian journal of basic medical sciences / Udruženje basičnih mediciniskih znanosti = Association of Basic Medical Sciences 2007;7(1):90-3.
2007: Zelija Velija-Asimi; Jasenko Karamehic
The effects of treatment of subclinical hypothyroidism on metabolic control and hyperinsulinemia.
Medicinski arhiv 2007;61(1):20-1.
2005: Zelija Velija-Asimi; Bećir Heljić
The effects of valsartan on lipid profile in normotensive type 2 diabetic patients.
Medicinski arhiv 2005;59(5):311-2.
2005: Bećir Heljić; Zelija Velija-Asimi; Azra Bureković; Belma Buturović; Armana Cerić; Bosanko Horozić; Dijana Sakambet; Amela Dizdarević-Bostandzić; Ismana Surković; Snjezana Hasanbegović; Dragan Stevanović
[LEAP (Lantus Early Access Programme) in Sarajevo].
Medicinski arhiv 2005;59(5):283-5.